Fervent Synergies Ltd: Intrinsic Value & Share Price Analysis

Q: What is the current share price and 52-week range of Fervent Synergies Ltd?

Fervent Synergies Ltd is trading at 18.30 as of 22 April 2026, with a FY2026-2027 high of 29.8 and low of 16.0. The stock is currently near its 52-week low. Market cap stands at 91.3 Cr..

Q: Is Fervent Synergies Ltd financially healthy?

Key indicators: ROCE of 7.47 % is on the lower side. Dividend yield is 0.00 %.

Q: Is Fervent Synergies Ltd profitable and how is the profit trend?

Fervent Synergies Ltd reported a net profit of 3 Cr in Mar 2025 on revenue of 32 Cr. Compared to 0 Cr in Mar 2022, the net profit shows an improving trend.

Fair Value

₹17.45Fairly Valued by 4.64%vs CMP ₹18.30

P/E (26.5) × ROE (7.5%) × BV (₹10.80) × DY (2.00%)

₹12.16Overvalued by 33.55%vs CMP ₹18.30

MoS: -50.5% (Negative)Confidence: 59/100 (Moderate)Models: 1 Fair, 7 Over

Model	Category	Value	Weight	Signal
PE-ROE	Earnings	₹19.60	26%	Fair (+7.1%)
Graham Number	Earnings	₹13.14	16%	Over (-28.2%)
DCF	Cash Flow	₹12.61	16%	Over (-31.1%)
Net Asset Value	Assets	₹10.85	8%	Over (-40.7%)
EV/EBITDA	Enterprise	₹7.28	11%	Over (-60.2%)
Earnings Yield	Earnings	₹7.10	8%	Over (-61.2%)
ROCE Capital	Returns	₹0.51	8%	Over (-97.2%)
Revenue Multiple	Revenue	₹9.76	6%	Over (-46.7%)
Consensus (8 models)		₹12.16	100%	Overvalued

Key Drivers: Wide model spread (₹1–₹20) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 12.3%

*Investments are subject to market risks

Analyst Summary

Fervent Synergies Ltd operates in the Pharmaceuticals segment, NSE: FERVENTSYN | BSE: 533896, current market price is ₹18.30, market cap is 91.3 Cr.. At a glance, stock P/E is 26.5, ROE is 7.47 %, ROCE is 7.47 %, book value is 10.8, dividend yield is 0.00 %. The latest intrinsic value estimate is ₹12.16, around 33.6% below the current price, so expectations may already be running ahead of this modelled fair value. On operating trend, latest reported sales are about ₹32 Cr versus the prior period change of 33.5%, while latest net profit is about ₹3 Cr with a prior-period change of 123.0%. The 52-week range shown on this page is 29.8/16.0, which helps frame where the current quote sits within its recent trading band. Business context: About the Company - Qualitative AnalysisFervent Synergies Ltd. is a Public Limited Listed company incorporated on 06/07/2009 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is…

This summary is generated from the stock page data available for Fervent Synergies Ltd: Intrinsic Value & Share Price Analysis and is refreshed automatically when the underlying metrics change.

Investment Snapshot

Fervent Synergies Ltd scores 46/100 (Average)

Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison

Stock Health53/100 · Moderate

ROCE 7.5% WeakROE 7.5% AverageD/E 0.00 Low debtInterest Coverage 0.0x RiskyProfitable 3/5 years Mixed

Smart Money50/100 · Moderate

Promoter holding at 74.8% Stable

Earnings Quality30/100 · Weak

OPM contracting (-8% → -22%) DecliningWorking capital: 463 days Capital intensive

Quarterly Momentum45/100 · Moderate

Revenue (4Q): -61% YoY DecliningOPM: 22.0% (up 13.0% YoY) Margin expansion

Industry Rank55/100 · Moderate

P/E 26.5 vs industry 53.8 Cheaper than peersROCE 7.5% vs industry 16.4% Below peersROE 7.5% vs industry 15.2% Below peers3Y sales CAGR: 263% High growth

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 4:36 am

Market Cap	91.3 Cr.
Current Price	18.3
Intrinsic Value	₹12.16
High / Low	29.8/16.0
Stock P/E	26.5
Book Value	10.8
Dividend Yield	0.00 %
ROCE	7.47 %
ROE	7.47 %
Face Value	10.0
PEG Ratio	2.15

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Fervent Synergies Ltd

Competitors

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Fervent Synergies Ltd	91.3 Cr.	18.3	29.8/16.0	26.5	10.8	0.00 %	7.47 %	7.47 %	10.0
Aarti Pharmalabs Ltd	5,757 Cr.	635	972/557	26.7	226	0.79 %	17.4 %	14.5 %	5.00
Morepen Laboratories Ltd	2,038 Cr.	37.2	70.5/33.0	26.7	21.8	0.54 %	15.1 %	11.8 %	2.00
Godavari Drugs Ltd	94.0 Cr.	92.8	115/69.7	26.8	60.3	0.00 %	10.1 %	10.6 %	10.0
Alkem Laboratories Ltd	62,655 Cr.	5,244	5,934/4,612	26.1	1,116	0.86 %	20.4 %	19.4 %	2.00
Industry Average	19,815.15 Cr	1,053.84		53.84	201.20	0.39%	16.35%	15.16%	6.10

All Competitor Stocks of Fervent Synergies Ltd

Quarterly Result

Metric	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	3.27	0.89	0.32	0.32	8.83	14.85	0.34	0.39	26.33	5.40	0.68	0.68	9.78
Expenses	3.08	0.74	0.18	0.18	8.32	28.40	0.26	0.34	23.97	4.90	0.29	0.24	7.63
Operating Profit	0.19	0.15	0.14	0.14	0.51	-13.55	0.08	0.05	2.36	0.50	0.39	0.44	2.15
OPM %	5.81%	16.85%	43.75%	43.75%	5.78%	-91.25%	23.53%	12.82%	8.96%	9.26%	57.35%	64.71%	21.98%
Other Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest	0.00	0.00	0.00	0.00	0.00	0.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Profit before tax	0.18	0.14	0.13	0.13	0.50	-13.60	0.07	0.04	2.35	0.49	0.38	0.43	2.14
Tax %	27.78%	100.00%	23.08%	23.08%	26.00%	-1.40%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Profit	0.14	0.00	0.10	0.09	0.37	-13.41	0.07	0.04	2.35	0.50	0.38	0.43	2.14
EPS in Rs	0.05	0.00	0.03	0.03	0.12	-4.47	0.02	0.01	0.54	0.11	0.08	0.09	0.43

Last Updated: March 3, 2026, 9:54 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 27, 2026, 5:10 am

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	2.63	3.51	3.67	39.15	5.51	16.67	7.35	2.21	0.68	4.63	24.31	32.46	16.54
Expenses	0.50	0.53	0.66	36.47	4.41	15.26	6.90	1.93	0.86	4.15	37.08	29.47	13.06
Operating Profit	2.13	2.98	3.01	2.68	1.10	1.41	0.45	0.28	-0.18	0.48	-12.77	2.99	3.48
OPM %	80.99%	84.90%	82.02%	6.85%	19.96%	8.46%	6.12%	12.67%	-26.47%	10.37%	-52.53%	9.21%	21.04%
Other Income	-0.04	0.00	-0.07	0.83	0.06	0.41	0.03	0.00	0.02	0.00	0.00	0.00	0.00
Interest	0.06	0.04	0.01	0.19	0.01	0.07	0.15	0.01	0.00	0.00	0.04	0.00	0.00
Depreciation	0.05	0.05	0.05	0.01	0.01	0.01	0.02	0.04	0.04	0.04	0.04	0.04	0.04
Profit before tax	1.98	2.89	2.88	3.31	1.14	1.74	0.31	0.23	-0.20	0.44	-12.85	2.95	3.44
Tax %	32.83%	32.53%	33.68%	27.19%	27.19%	28.74%	25.81%	26.09%	20.00%	47.73%	0.00%	0.00%
Net Profit	1.33	1.95	1.91	2.41	0.83	1.23	0.24	0.17	-0.24	0.23	-12.84	2.95	3.45
EPS in Rs	0.53	0.65	0.64	0.80	0.28	0.41	0.08	0.06	-0.08	0.08	-4.28	0.67	0.71
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	46.62%	-2.05%	26.18%	-65.56%	48.19%	-80.49%	-29.17%	-241.18%	195.83%	-5682.61%	122.98%
Change in YoY Net Profit Growth (%)	0.00%	-48.67%	28.23%	-91.74%	113.75%	-128.68%	51.32%	-212.01%	437.01%	-5878.44%	5805.58%

Fervent Synergies Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	25%
5 Years:	35%
3 Years:	263%
TTM:	35%

Compounded Profit Growth
10 Years:	4%
5 Years:	65%
3 Years:	143%
TTM:	125%

Stock Price CAGR
10 Years:	1%
5 Years:	19%
3 Years:	19%
1 Year:	13%

Return on Equity
10 Years:	-1%
5 Years:	-5%
3 Years:	-8%
Last Year:	7%

Last Updated: September 5, 2025, 3:30 pm

Balance Sheet

Last Updated: March 3, 2026, 2:57 am

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sep 2025
Equity Capital	25.00	30.00	30.00	30.00	30.00	30.00	30.00	30.00	30.00	30.00	30.00	43.75	50.00
Reserves	3.49	6.44	8.34	10.75	11.80	12.78	12.58	13.04	12.99	13.22	0.38	4.89	4.15
Borrowings	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.03
Other Liabilities	0.72	1.02	1.02	1.49	0.39	0.71	0.82	0.70	0.14	0.23	0.14	0.14	0.10
Total Liabilities	29.21	37.46	39.36	42.24	42.19	43.49	43.40	43.74	43.13	43.45	30.52	48.78	54.28
Fixed Assets	0.49	0.48	0.45	1.94	3.57	17.60	17.79	17.76	16.10	16.06	7.52	7.48	7.47
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	1.00	0.00	2.16	0.00	0.97	0.72	0.28	0.57	0.00	0.00	0.00	0.00	0.00
Other Assets	27.72	36.98	36.75	40.30	37.65	25.17	25.33	25.41	27.03	27.39	23.00	41.30	46.81
Total Assets	29.21	37.46	39.36	42.24	42.19	43.49	43.40	43.74	43.13	43.45	30.52	48.78	54.28

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	-3.66	1.06	-6.28	-1.82	2.85	11.58	1.95	0.18	-2.19	-0.07	-0.20	-15.08
Cash from Investing Activity +	0.00	1.00	-2.14	1.19	-2.39	-14.03	-0.22	0.00	2.40	0.00	0.00	0.00
Cash from Financing Activity +	0.00	6.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	15.12
Net Cash Flow	-3.66	8.06	-8.41	-0.63	0.46	-2.46	1.73	0.18	0.21	-0.07	-0.20	0.04
Free Cash Flow	-3.66	1.06	-6.28	-1.83	2.85	11.57	1.74	0.17	-2.20	-0.07	-0.20	-15.08
CFO/OP	-143%	68%	-177%	-40%	305%	839%	504%	89%	1,161%	6%	0%	-502%

Free Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	2.13	2.98	3.01	2.68	1.10	1.41	0.45	0.28	-0.18	0.48	-12.77	2.99

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	0.00	0.00	0.00	42.61	46.37	66.12	131.60	289.03	0.00	47.30	0.00	0.00
Inventory Days				12.16	0.00	0.00	80.66	0.00		0.00	0.00	0.00
Days Payable				0.00			0.00
Cash Conversion Cycle	0.00	0.00	0.00	54.77	46.37	66.12	212.26	289.03	0.00	47.30	0.00	0.00
Working Capital Days	1,992.93	1,589.99	2,337.19	256.20	1,437.48	248.95	482.20	3,260.23	14,331.62	2,132.45	344.58	463.17
ROCE %	7.48%	9.09%	8.02%	7.51%	2.79%	4.28%	1.08%	0.56%	-0.46%	1.02%	-34.81%	7.47%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoters	73.33%	73.33%	73.33%	73.33%	73.33%	73.33%	73.33%	73.33%	71.71%	74.75%	74.75%	74.75%
Public	26.68%	26.67%	26.66%	26.66%	26.66%	26.67%	26.66%	26.66%	28.29%	25.25%	25.25%	25.26%
No. of Shareholders	2,879	2,827	2,830	2,961	3,110	3,225	3,360	3,476	3,684	3,598	3,713	3,711

Shareholding Pattern Chart

No. of Shareholders

Fervent Synergies Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	0.68	-4.28	0.08	-0.08	0.06
Diluted EPS (Rs.)	0.59	-4.28	0.08	-0.08	0.06
Cash EPS (Rs.)	0.68	-4.27	0.09	-0.06	0.07
Book Value[Excl.RevalReserv]/Share (Rs.)	11.12	10.13	14.40	14.33	14.35
Book Value[Incl.RevalReserv]/Share (Rs.)	11.12	10.13	14.40	14.33	14.35
Revenue From Operations / Share (Rs.)	7.42	8.10	1.54	0.22	0.73
PBDIT / Share (Rs.)	0.68	-4.25	0.15	-0.05	0.09
PBIT / Share (Rs.)	0.67	-4.27	0.14	-0.06	0.08
PBT / Share (Rs.)	0.67	-4.28	0.14	-0.06	0.07
Net Profit / Share (Rs.)	0.67	-4.28	0.07	-0.07	0.05
PBDIT Margin (%)	9.20	-52.50	10.32	-23.56	12.63
PBIT Margin (%)	9.08	-52.67	9.45	-29.04	10.98
PBT Margin (%)	9.08	-52.84	9.45	-29.11	10.60
Net Profit Margin (%)	9.09	-52.82	4.97	-34.94	7.89
Return on Networth / Equity (%)	6.07	-42.27	0.53	-0.55	0.40
Return on Capital Employeed (%)	6.05	-42.00	1.01	-0.45	0.56
Return On Assets (%)	6.05	-42.08	0.52	-0.55	0.39
Asset Turnover Ratio (%)	0.81	0.65	0.10	0.01	0.05
Current Ratio (X)	1166.31	795.38	205.92	781.01	43.67
Quick Ratio (X)	1166.31	795.38	205.92	781.01	43.67
Interest Coverage Ratio (X)	14935.00	-304.63	2389.00	-320.60	33.04
Interest Coverage Ratio (Post Tax) (X)	14769.00	-305.48	1152.50	-474.40	21.64
Enterprise Value (Cr.)	96.89	62.69	48.33	44.11	39.38
EV / Net Operating Revenue (X)	2.99	2.58	10.44	64.84	17.81
EV / EBITDA (X)	32.44	-4.91	101.15	-275.19	140.94
MarketCap / Net Operating Revenue (X)	2.99	2.58	10.48	65.27	20.11
Price / BV (X)	1.99	2.06	1.12	1.03	1.03
Price / Net Operating Revenue (X)	2.99	2.58	10.49	65.49	20.11
EarningsYield	0.03	-0.20	0.00	-0.01	0.00

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Fervent Synergies Ltd. is a Public Limited Listed company incorporated on 06/07/2009 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH2009PLC193843 and registration number is 193843. Currently Company is involved in the business activities of Wholesale of other basic/manufactured food stuffs. Company's Total Operating Revenue is Rs. 32.46 Cr. and Equity Capital is Rs. 43.75 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Pharmaceuticals	B/7-8, Satyam Shopping Centre, Mumbai Maharashtra 400077	Contact not found

Management
Name	Position Held
Mr. Vijay P Thakkar	Chairman
Mr. Sanjay P Thakkar	Managing Director
Mr. Karan Thakkar	Director & CFO
Mr. Nitin Parikh	Independent Director
Mr. Rajesh Maheshwari	Independent Director
Mrs. Falguni Mehta	Independent Director

FAQ

What is the intrinsic value of Fervent Synergies Ltd and is it undervalued?

As of 22 April 2026, Fervent Synergies Ltd's intrinsic value is ₹12.16, which is 33.55% lower than the current market price of ₹18.30, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (7.47 %), book value (₹10.8), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Fervent Synergies Ltd?

Fervent Synergies Ltd is trading at ₹18.30 as of 22 April 2026, with a FY2026-2027 high of ₹29.8 and low of ₹16.0. The stock is currently near its 52-week low. Market cap stands at ₹91.3 Cr..

How does Fervent Synergies Ltd's P/E ratio compare to its industry?

Fervent Synergies Ltd has a P/E ratio of 26.5, which is below the industry average of 53.84. Trading at a steep discount to peers could signal a value opportunity or reflect concerns about the company's fundamentals.

Is Fervent Synergies Ltd financially healthy?

Key indicators for Fervent Synergies Ltd: ROCE of 7.47 % is on the lower side compared to the industry average of 16.35%; ROE of 7.47 % is below ideal levels (industry average: 15.16%). Dividend yield is 0.00 %.

Is Fervent Synergies Ltd profitable and how is the profit trend?

Fervent Synergies Ltd reported a net profit of ₹3 Cr in Mar 2025 on revenue of ₹32 Cr. Compared to ₹0 Cr in Mar 2022, the net profit shows an improving trend.

Does Fervent Synergies Ltd pay dividends?

Fervent Synergies Ltd has a dividend yield of 0.00 % at the current price of ₹18.30. The company is currently not paying meaningful dividends.